title: Cocaine and phenylephrine eye drop test for Parkinson disease.
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Sawada
authors.forename: Kentarou
authors.initials: K
authors.lastname: Yamakawa
authors.forename: Hodaka
authors.initials: H
authors.lastname: Yamakado
authors.forename: Ryohei
authors.initials: R
authors.lastname: Hosokawa
authors.forename: Muneo
authors.initials: M
authors.lastname: Ohba
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Miyamoto
authors.forename: Takashi
authors.initials: T
authors.lastname: Kawamura
authors.forename: Shun
authors.initials: S
authors.lastname: Shimohama
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage; D000368:Aged; D003042:Cocaine / Q000008:administration & dosage; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015878:Mydriasis / Q000139:chemically induced; D009883:Ophthalmic Solutions; D010300:Parkinson Disease / Q000175:diagnosis*; D010656:Phenylephrine / Q000008:administration & dosage; D011680:Pupil / Q000187:drug effects*; D013564:Sympathetic Nervous System
chemical_list: D000316:Adrenergic alpha-Agonists; D018765:Dopamine Uptake Inhibitors; D009883:Ophthalmic Solutions; D010656:Phenylephrine; D003042:Cocaine